Autosomal dominant familial dyskinesia and facial myokymia: single exome sequencing identifies a mutation in adenylyl cyclase 5
- PMID: 22782511
- PMCID: PMC3508680
- DOI: 10.1001/archneurol.2012.54
Autosomal dominant familial dyskinesia and facial myokymia: single exome sequencing identifies a mutation in adenylyl cyclase 5
Abstract
Background: Familial dyskinesia with facial myokymia (FDFM) is an autosomal dominant disorder that is exacerbated by anxiety. In a 5-generation family of German ancestry, we previously mapped FDFM to chromosome band 3p21-3q21. The 72.5-Mb linkage region was too large for traditional positional mutation identification.
Objective: To identify the gene responsible for FDFM by exome resequencing of a single affected individual.
Participants: We performed whole exome sequencing in 1 affected individual and used a series of bioinformatic filters, including functional significance and presence in dbSNP or the 1000 Genomes Project, to reduce the number of candidate variants. Co-segregation analysis was performed in 15 additional individuals in 3 generations.
Main outcome measures: Unique DNA variants in the linkage region that co-segregate with FDFM.
Results: The exome contained 23 428 single-nucleotide variants, of which 9391 were missense, nonsense, or splice site alterations. The critical region contained 323 variants, 5 of which were not present in 1 of the sequence databases. Adenylyl cyclase 5 (ADCY5) was the only gene in which the variant (c.2176G>A) was co-transmitted perfectly with disease status and was not present in 3510 control white exomes. This residue is highly conserved, and the change is nonconservative and predicted to be damaging.
Conclusions: ADCY5 is highly expressed in striatum. Mice deficient in Adcy5 develop a movement disorder that is worsened by stress. We conclude that FDFM likely results from a missense mutation in ADCY5. This study demonstrates the power of a single exome sequence combined with linkage information to identify causative genes for rare autosomal dominant mendelian diseases.
Figures


Similar articles
-
Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymia.Ann Neurol. 2014 Apr;75(4):542-9. doi: 10.1002/ana.24119. Epub 2014 Mar 13. Ann Neurol. 2014. PMID: 24700542 Free PMC article.
-
ADCY5-related dyskinesia presenting as familial myoclonus-dystonia.Neurogenetics. 2017 Apr;18(2):111-117. doi: 10.1007/s10048-017-0510-z. Epub 2017 Feb 22. Neurogenetics. 2017. PMID: 28229249 Free PMC article.
-
A de novo ADCY5 mutation causes early-onset autosomal dominant chorea and dystonia.Mov Disord. 2015 Mar;30(3):423-7. doi: 10.1002/mds.26115. Epub 2014 Dec 27. Mov Disord. 2015. PMID: 25545163
-
An Update on the Phenotype, Genotype and Neurobiology of ADCY5-Related Disease.Mov Disord. 2021 May;36(5):1104-1114. doi: 10.1002/mds.28495. Epub 2021 May 2. Mov Disord. 2021. PMID: 33934385 Review.
-
[ADCY5-associated dyskinesia in young children: a case report of a family and an updated review].Rev Neurol. 2020 Jul 16;71(2):69-73. doi: 10.33588/rn.7102.2020154. Rev Neurol. 2020. PMID: 32627162 Review. Spanish.
Cited by
-
Recent advances in genetics of chorea.Curr Opin Neurol. 2016 Aug;29(4):486-95. doi: 10.1097/WCO.0000000000000352. Curr Opin Neurol. 2016. PMID: 27257945 Free PMC article. Review.
-
Heterozygous STUB1 missense variants cause ataxia, cognitive decline, and STUB1 mislocalization.Neurol Genet. 2020 Feb 10;6(2):1-13. doi: 10.1212/NXG.0000000000000397. eCollection 2020 Apr. Neurol Genet. 2020. PMID: 32211513 Free PMC article.
-
Paroxysmal Movement Disorders.Front Neurol. 2021 Jun 11;12:659064. doi: 10.3389/fneur.2021.659064. eCollection 2021. Front Neurol. 2021. PMID: 34177764 Free PMC article. Review.
-
ADCY5-Induced Dyskinetic Storm Rescued with Pallidal Deep Brain Stimulation in a 46-Year-Old Man.Mov Disord Clin Pract. 2020 Sep 21;8(1):142-144. doi: 10.1002/mdc3.13076. eCollection 2021 Jan. Mov Disord Clin Pract. 2020. PMID: 33426171 Free PMC article. No abstract available.
-
Some New and Unexpected Tauopathies in Movement Disorders.Mov Disord Clin Pract. 2020 Aug 3;7(6):616-626. doi: 10.1002/mdc3.12995. eCollection 2020 Aug. Mov Disord Clin Pract. 2020. PMID: 32775506 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
- UC2 HL102926/HL/NHLBI NIH HHS/United States
- RC2 HG005608/HG/NHGRI NIH HHS/United States
- R01 NS069719/NS/NINDS NIH HHS/United States
- HL 102926/HL/NHLBI NIH HHS/United States
- RC2HG005608/HG/NHGRI NIH HHS/United States
- HL 102924/HL/NHLBI NIH HHS/United States
- UC2 HL102924/HL/NHLBI NIH HHS/United States
- HHMI/Howard Hughes Medical Institute/United States
- HL 1029230/HL/NHLBI NIH HHS/United States
- RC2 HL102926/HL/NHLBI NIH HHS/United States
- R01NS069719/NS/NINDS NIH HHS/United States
- RC2 HL102924/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous